Literature DB >> 24958953

Recombinant Human Growth Hormone: HIV-Related Lipodystrophy.

Joyce A Generali1, Dennis J Cada2.   

Abstract

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@ku.edu.

Entities:  

Year:  2014        PMID： 24958953      PMCID： PMC4062715          DOI： 10.1310/hpj4905-432

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN： 0018-5787


  9 in total

1.  Effects of growth hormone on visceral adipose tissue and dyslipidemia in HIV, an erratum.

Authors:  Donald P Kotler; Norma Muurahainen; Carl Grunfeld; Christine Wanke; Melanie Thompson; Michael Saag; Daena Bock; Gregg Simons; Joseph M Gertner
Journal:  J Acquir Immune Defic Syndr       Date:  2006-11-01       Impact factor: 3.731

2.  Recombinant human growth hormone improves the fat redistribution syndrome (lipodystrophy) in patients with HIV.

Authors:  C Wanke; J Gerrior; J Kantaros; E Coakley; M Albrecht
Journal:  AIDS       Date:  1999-10-22       Impact factor: 4.177

Review 3.  Growth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled trials.

Authors:  T Sivakumar; Oj Mechanic; D A Fehmie; Bt Paul
Journal:  HIV Med       Date:  2011-01-25       Impact factor: 3.180

Review 4.  Recombinant human growth hormone: rationale for use in the treatment of HIV-associated lipodystrophy.

Authors:  Stefano Benedini; Ileana Terruzzi; Adriano Lazzarin; Livio Luzi
Journal:  BioDrugs       Date:  2008       Impact factor: 5.807

5.  Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial.

Authors:  Janet Lo; Sung Min You; Bridget Canavan; James Liebau; Greg Beltrani; Polyxeni Koutkia; Linda Hemphill; Hang Lee; Steven Grinspoon
Journal:  JAMA       Date:  2008-08-06       Impact factor: 56.272

6.  Effect of recombinant human growth hormone in the treatment of visceral fat accumulation in HIV infection.

Authors:  Ellen S Engelson; Marshall J Glesby; Douglas Mendez; Jeanine B Albu; Jack Wang; Steven B Heymsfield; Donald P Kotler
Journal:  J Acquir Immune Defic Syndr       Date:  2002-08-01       Impact factor: 3.731

7.  Recombinant human growth hormone to treat HIV-associated adipose redistribution syndrome: 12 week induction and 24-week maintenance therapy.

Authors:  Carl Grunfeld; Melanie Thompson; Stephen J Brown; Gary Richmond; Daniel Lee; Norma Muurahainen; Donald P Kotler
Journal:  J Acquir Immune Defic Syndr       Date:  2007-07-01       Impact factor: 3.731

8.  Treatment of altered body composition in HIV-associated lipodystrophy: comparison of rosiglitazone, pravastatin, and recombinant human growth hormone.

Authors:  Derek C Macallan; Christine Baldwin; Sundihya Mandalia; Vjera Pandol-Kaljevic; Nadine Higgins; Alan Grundy; Graeme J Moyle
Journal:  HIV Clin Trials       Date:  2008 Jul-Aug

9.  Recombinant human growth hormone and rosiglitazone for abdominal fat accumulation in HIV-infected patients with insulin resistance: a randomized, double-blind, placebo-controlled, factorial trial.

Authors:  Marshall J Glesby; Jeanine Albu; Ya-Lin Chiu; Kirsis Ham; Ellen Engelson; Qing He; Varalakshmi Muthukrishnan; Henry N Ginsberg; Daniel Donovan; Jerry Ernst; Martin Lesser; Donald P Kotler
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240
  9 in total
  1 in total

1.  Availability and quality of illegitimate somatropin products obtained from the Internet.

Authors:  Róbert György Vida; András Fittler; Ivett Mikulka; Eszter Ábrahám; Viktor Sándor; Ferenc Kilár; Lajos Botz
Journal:  Int J Clin Pharm       Date:  2016-11-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.